Literature DB >> 1998331

Prenatal screening for hemoglobinopathies. II. Evaluation of counseling.

S Loader1, C J Sutera, M Walden, A Kozyra, P T Rowley.   

Abstract

Learning during genetic counseling is often below expectations, especially in the context of genetic screening. In this report we describe learning as a result of genetic counseling of 298 pregnant women identified as hemoglobinopathy carriers, 234 with sickle cell trait and 64 with beta-thalassemia trait. Counseling was designed to provide the information needed in a simple, clear, and nondirective manner. A special videotape produced for this purpose provided dramatization and a role model illustrating an appropriate response. After viewing the videotape the counselee had an opportunity to question the counselor and to have any misconceptions corrected. Questionnaires revealed significantly increased knowledge as a result of counseling in each of the three hemoglobinopathy subject areas tested-namely, clinical manifestations, genetics, and prenatal diagnosis. Five factors correlated with higher knowledge scores after counseling-namely, a younger patient age, more years of education, knowledge of having trait before this identification, knowledge of the baby's father having trait before counseling, and having no prior children.

Entities:  

Mesh:

Year:  1991        PMID: 1998331      PMCID: PMC1682977     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  6 in total

1.  The evaluation of genetic counseling. A committee report.

Authors:  I M Rosenstock
Journal:  Public Health Rep       Date:  1977 Jul-Aug       Impact factor: 2.792

Review 2.  Impact of genetic counseling: a review of published follow-up studies.

Authors:  G Evers-Kiebooms; H van den Berghe
Journal:  Clin Genet       Date:  1979-06       Impact factor: 4.438

3.  Genetic counseling: a consumers' view.

Authors:  C O Leonard; G A Chase; B Childs
Journal:  N Engl J Med       Date:  1972-08-31       Impact factor: 91.245

4.  Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: comparison of three counseling methods.

Authors:  P T Rowley; M Lipkin; L Fisher
Journal:  Am J Hum Genet       Date:  1984-05       Impact factor: 11.025

5.  Tay-Sachs screening: motives for participating and knowledge of genetics and probability.

Authors:  B Childs; L Gordis; M M Kaback; H H Kazazian
Journal:  Am J Hum Genet       Date:  1976-11       Impact factor: 11.025

6.  Prenatal screening for hemoglobinopathies. I. A prospective regional trial.

Authors:  P T Rowley; S Loader; C J Sutera; M Walden; A Kozyra
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

  6 in total
  8 in total

1.  A comparison of two approaches to education about carrier testing for cystic fibrosis.

Authors:  K P Leonard; L K Bartholomew; P R Swank; G S Parcel
Journal:  J Genet Couns       Date:  1995-06       Impact factor: 2.537

2.  Prenatal screening for hemoglobinopathies.

Authors:  J E Bowman
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

3.  PCR-based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population.

Authors:  W W Grody; C Dunkel-Schetter; Z H Tatsugawa; M A Fox; C Y Fang; R M Cantor; J M Novak; H N Bass; B F Crandall
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

4.  Parents' experiences of universal screening for haemoglobin disorders: implications for practice in a new genetics era.

Authors:  Louise Locock; Joe Kai
Journal:  Br J Gen Pract       Date:  2008-03       Impact factor: 5.386

5.  Prenatal genetic counseling for hemoglobinopathy carriers: a comparison of primary providers of prenatal care and professional genetic counselors.

Authors:  P T Rowley; S Loader; C J Sutera; A Kozyra
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

6.  Prenatal hemoglobinopathy screening. IV. Follow-up of women at risk for a child with a clinically significant hemoglobinopathy.

Authors:  S Loader; C J Sutera; S G Segelman; A Kozyra; P T Rowley
Journal:  Am J Hum Genet       Date:  1991-12       Impact factor: 11.025

7.  Prenatal screening for hemoglobinopathies. III. Applicability of the health belief model.

Authors:  P T Rowley; S Loader; C J Sutera; M Walden; A Kozyra
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

8.  COVID-19 and the adaptive evolution of genetic counseling.

Authors:  Nathan C Hassel; Adel D Gilbert; Bassem A Bejjani
Journal:  J Genet Couns       Date:  2022-03-18       Impact factor: 2.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.